P1 adhesin genotype characteristics of in China from 2017 to 2019.

Shirong Li, Haiwei Dou, Dawei Shi, Ruijie Yuan, Peng Tu, Qing Yuan, Deli Xin, Wenjie Qi
Author Information
  1. Shirong Li: Department of Infectious Disease, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
  2. Haiwei Dou: Department of Infectious Disease, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
  3. Dawei Shi: Department of Pediatrics, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
  4. Ruijie Yuan: Department of Geriatric Medicine, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, People's Hospital of Henan University, Zhengzhou, Henan, China.
  5. Peng Tu: Department of Pediatrics, Traditional Chinese and Western Medicine Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology; Wuhan No.1 Hospital, Wuhan, China.
  6. Qing Yuan: Department of Respiratory, Branch of Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Luoyang Hospital of TCM, Henan, China.
  7. Deli Xin: Department of Infectious Disease, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
  8. Wenjie Qi: Department of Infectious Disease, Beijing Friendship Hospital, Capital Medical University, Beijing, China.

Abstract

Introduction: is one of the important pathogens of community-acquired pneumonia (CAP), and P1 adhesin serves as a pathogenic protein and an immune protein involved in the pathogenesis of . The aim of this study was to investigate the P1 adhesin genotype in and its association with disease severity in patients with CAP from 2017 to 2019.
Methods: was identified in patient samples by real-time quantitative polymerase chain reaction (qPCR). The P1 genotypes of samples were determined using a culture-independent P1 typing method.
Results: In total, 1,907 clinical samples were collected from 13 tertiary hospitals in Beijing, Shenyang, and Baotou, including 1488 samples from children and 419 from adults. Of these, 820 samples (43.00%), including 777 from children and 43 from adults, were positive for . 797 samples were successfully typed using the culture-independent P1 typing method (P1-1, 605; P1- 2, 192). The detection rate and P1-1 detection rate differed significantly between children and adults (both < 0.01), with P1-1 remaining the dominant genotype. The proportion of P1-2 samples increased in children from 16.75% in 2017 to 28.76% in 2019.
Discussion: No relationship between the P1 genotype and disease severity was identified. Monitoring the genotype changes of P1 adhesin in local populations may positively impact the epidemiological prevention and control of infections.

Keywords

References

  1. J Microbiol Methods. 2010 Sep;82(3):214-22 [PMID: 20547188]
  2. Biochem Biophys Res Commun. 2019 Jan 22;508(4):1050-1055 [PMID: 30551878]
  3. Microbiol Spectr. 2024 Aug 6;12(8):e0361523 [PMID: 38904371]
  4. Front Microbiol. 2024 Aug 06;15:1449511 [PMID: 39171272]
  5. Infect Immun. 1982 Jul;37(1):382-6 [PMID: 6809635]
  6. J Clin Microbiol. 2014 Dec;52(12):4168-71 [PMID: 25232156]
  7. FEMS Microbiol Rev. 2008 Nov;32(6):956-73 [PMID: 18754792]
  8. Clin Microbiol Rev. 2017 Jul;30(3):747-809 [PMID: 28539503]
  9. Microbiol Spectr. 2023 Mar 13;:e0448922 [PMID: 36912679]
  10. Euro Surveill. 2015;20(37): [PMID: 26536357]
  11. Jpn J Infect Dis. 2017 Nov 22;70(6):642-646 [PMID: 29093323]
  12. New Microbes New Infect. 2015 May 23;7:37-40 [PMID: 26236493]
  13. N Engl J Med. 2015 Feb 26;372(9):835-45 [PMID: 25714161]
  14. Front Microbiol. 2024 Aug 14;15:1427702 [PMID: 39206369]
  15. Front Microbiol. 2016 Jun 28;7:960 [PMID: 27446003]
  16. J Glob Antimicrob Resist. 2022 Mar;28:180-184 [PMID: 35017067]
  17. BMC Infect Dis. 2010 Feb 25;10:39 [PMID: 20184731]
  18. Epidemiol Infect. 2010 Dec;138(12):1829-37 [PMID: 20334729]
  19. J Clin Microbiol. 2012 Nov;50(11):3620-6 [PMID: 22952264]
  20. Clin Infect Dis. 2020 Oct 23;71(7):1645-1654 [PMID: 31665253]
  21. Biomed Res Int. 2014;2014:320801 [PMID: 24592385]
  22. J Med Microbiol. 2008 Apr;57(Pt 4):469-475 [PMID: 18349367]
  23. J Clin Microbiol. 2006 Jul;44(7):2567-70 [PMID: 16825381]
  24. Front Microbiol. 2024 Oct 15;15:1483152 [PMID: 39473854]
  25. Antimicrob Agents Chemother. 2008 Jan;52(1):348-50 [PMID: 17954691]
  26. Emerg Infect Dis. 2018 Mar;24(3):506-513 [PMID: 29460736]
  27. J Clin Microbiol. 2015 Oct;53(10):3195-203 [PMID: 26202118]
  28. Infect Immun. 1990 Aug;58(8):2464-9 [PMID: 1695202]
  29. Bosn J Basic Med Sci. 2019 Aug 20;19(3):288-296 [PMID: 30878034]
  30. J Clin Microbiol. 2021 Jun 18;59(7):e0074821 [PMID: 33853838]
  31. Am J Respir Crit Care Med. 2019 Oct 1;200(7):e45-e67 [PMID: 31573350]
  32. Eur J Clin Microbiol Infect Dis. 2018 Jul;37(7):1265-1272 [PMID: 29603035]
  33. Clin Microbiol Infect. 2013 Apr;19(4):E212-7 [PMID: 23279613]
  34. Chest. 2011 Aug;140(2):401-407 [PMID: 21622549]
  35. BMJ. 2017 Mar 2;356:j686 [PMID: 28255071]
  36. JAMA. 2020 Mar 3;323(9):885-886 [PMID: 32027358]
  37. J Glob Antimicrob Resist. 2021 Dec;27:273-278 [PMID: 34687926]
  38. J Clin Microbiol. 2017 Jul;55(7):2222-2233 [PMID: 28490485]
  39. Int J Med Microbiol. 2004 Sep;294(2-3):149-55 [PMID: 15493825]
  40. Clin Infect Dis. 2019 Jan 1;68(1):13-14 [PMID: 29788200]
  41. Jpn J Infect Dis. 2020 Jan 23;73(1):14-18 [PMID: 31474699]
  42. Infect Drug Resist. 2022 Aug 11;15:4443-4452 [PMID: 35983294]
  43. Exp Ther Med. 2017 Sep;14(3):1892-1898 [PMID: 28962100]
  44. J Clin Microbiol. 2007 Nov;45(11):3534-9 [PMID: 17881549]
  45. J Clin Microbiol. 2019 May 24;57(6): [PMID: 30918047]
  46. Microb Pathog. 2005 Oct;39(4):149-58 [PMID: 16169702]
  47. BMC Microbiol. 2024 Jan 17;24(1):23 [PMID: 38229068]
  48. Int J Infect Dis. 2018 Jan;66:113-120 [PMID: 29155089]
  49. Int J Med Microbiol. 2015 Oct;305(7):705-8 [PMID: 26319941]
  50. BMC Infect Dis. 2022 Sep 6;22(1):724 [PMID: 36068499]
  51. Infect Immun. 1990 Jun;58(6):2017-20 [PMID: 1971263]
  52. J Clin Microbiol. 2009 Apr;47(4):914-23 [PMID: 19204097]
  53. Emerg Microbes Infect. 2025 Dec;14(1):2449087 [PMID: 39760260]
  54. J Clin Microbiol. 1996 Feb;34(2):447-9 [PMID: 8789036]
  55. Emerg Infect Dis. 2015 Mar;21(3):426-34 [PMID: 25693633]
  56. J Clin Microbiol. 2021 Jul 19;59(8):e0022021 [PMID: 33980654]
  57. JAMA Dermatol. 2020 Feb 1;156(2):144-150 [PMID: 31851288]
  58. Mol Microbiol. 2017 Sep;105(6):869-879 [PMID: 28671286]
  59. PLoS One. 2017 Jan 20;12(1):e0170253 [PMID: 28107399]
  60. Nat Commun. 2020 Oct 14;11(1):5188 [PMID: 33057023]
  61. PLoS One. 2015 Oct 28;10(10):e0141702 [PMID: 26509651]

MeSH Term

Humans
Mycoplasma pneumoniae
Adhesins, Bacterial
Pneumonia, Mycoplasma
Genotype
China
Child
Adult
Male
Female
Child, Preschool
Adolescent
Community-Acquired Infections
Middle Aged
Young Adult
Infant
Severity of Illness Index
Aged

Chemicals

Adhesins, Bacterial
adhesin, Mycoplasma pneumoniae

Word Cloud

Created with Highcharts 10.0.0P1samplesgenotypeadhesinchildren20172019adultsP1-1community-acquiredpneumoniaCAPproteindiseaseseverityidentifiedusingculture-independenttypingmethodincluding43detectionrateIntroduction:oneimportantpathogensservespathogenicimmuneinvolvedpathogenesisaimstudyinvestigateassociationpatientsMethods:patientreal-timequantitativepolymerasechainreactionqPCRgenotypesdeterminedResults:total1907clinicalcollected13tertiaryhospitalsBeijingShenyangBaotou148841982000%777positive797successfullytyped605P1-2192differedsignificantly<001remainingdominantproportionP1-2increased1675%2876%Discussion:relationshipMonitoringchangeslocalpopulationsmaypositivelyimpactepidemiologicalpreventioncontrolinfectionscharacteristicsChinaMycoplasmapneumoniaegeneprevalence

Similar Articles

Cited By